A blockbuster drug that transformed diabetes and weight loss care may hold an unexpected benefit for people with bipolar disorder. Researchers at Griffith University found that people with bipolar disorder were less likely to require psychiatric hospitalization while taking semaglutide, the active ingredient in Ozempic and Wegovy. The result raises the possibility that some glucagon-like […]This is a curated summary.